Sandler Alan B.
Reporting owner on Forms 3, 4 and 5, CIK 1835966.
Sandler Alan B. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-01.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Revolution Medicines, Inc. CIK 1628171 | officer (Chief Development Officer) | 1 | 2026-10-01 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | M exercised | +6,000 | $58.84 | 58,868 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | S sold | -2,200 | $200.8188 | 56,668 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | S sold | -1,609 | $201.7239 | 55,059 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | S sold | -1,000 | $202.8127 | 54,059 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | S sold | -1,199 | $203.9074 | 52,860 | Form 4 |
| Revolution Medicines, Inc. Common Stock | 2026-09-29 | S sold | -301 | $204.7224 | 52,559 | Form 4 |
| Revolution Medicines, Inc. Stock Option (Right to Buy), derivative | 2026-09-29 | M exercised | -6,000 | $0 | 161,300 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001835966-26-000008 | Revolution Medicines, Inc. | 2026-10-01 |